| 摘要 |
The present invention provides a method for treating allergic dermatitis, atopic dermatitis, or one or more symptoms thereof in a dog in need, which method comprises administering to the dog a first therapeutically effective dose of the Janus Kinase-1 (JAK-1) inhibitor, N-methyl-1-{ trans-4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl} methanesulfonamide or a pharmaceutically acceptable salt thereof, twice a day for up to 14 days followed by a second once-a-day therapeutic effective dose of the JAK-1 inhibitor for up to 112 days. |
